Pneumococcal vaccine and HIV-1 infection

被引：2
|
作者：
Fedson, DS [1 ]
Watson, M
机构：
[1] Aventis Pasteur MSD, F-69367 Lyon 07, France
[2] Aventis Pasteur MSD, Maidenhead, Berks, England
来源：
LANCET | 2000年 / 356卷 / 9237期
关键词：
D O I：
10.1016/S0140-6736(05)73873-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1272 / 1272
页数：1
相关论文
共 50 条
  • [41] Is developing an HIV-1 vaccine possible?
    Haynes, Barton F.
    Liao, Hua-Xin
    Tomaras, Georgia D.
    [J]. CURRENT OPINION IN HIV AND AIDS, 2010, 5 (05) : 362 - 367
  • [42] HIV-1 diversity and vaccine development
    Nabel, G
    Makgoba, W
    Esparza, J
    [J]. SCIENCE, 2002, 296 (5577) : 2335 - 2335
  • [43] Novel vaccine vectors for HIV-1
    Barouch, Dan H.
    Picker, Louis J.
    [J]. NATURE REVIEWS MICROBIOLOGY, 2014, 12 (11) : 765 - 771
  • [44] Polynucleotide vaccine against HIV-1
    Moelling, K
    [J]. RETROVIRUSES OF HUMAN AIDS AND RELATED ANIMAL DISEASES, 1996, : 303 - 307
  • [45] Challenges in the development of an HIV-1 vaccine
    Barouch, Dan H.
    [J]. NATURE, 2008, 455 (7213) : 613 - 619
  • [46] Progress in HIV-1 vaccine development
    Haynes, Barton F.
    McElrath, M. Juliana
    [J]. CURRENT OPINION IN HIV AND AIDS, 2013, 8 (04) : 326 - 332
  • [47] Advances in HIV-1 Vaccine Development
    Gao, Yong
    McKay, Paul E.
    Mann, Jamie E. S.
    [J]. VIRUSES-BASEL, 2018, 10 (04):
  • [48] Crystallography and HIV-1 vaccine design
    Kwong, Peter D.
    [J]. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2011, 67 : C6 - C6
  • [49] Progress in the development of an HIV-1 vaccine
    Letvin, NL
    [J]. SCIENCE, 1998, 280 (5371) : 1875 - 1880
  • [50] Challenges in the development of an HIV-1 vaccine
    Dan H. Barouch
    [J]. Nature, 2008, 455 : 613 - 619
12345